A ranar 10 ga Maris, 2026, sabuwar na'urar B7-H3 mai targeting antibody-drug conjugate (ADC) YL201 don allura, wadda MediLink Therapeutics ta ƙirƙiro, an ba ta izinin naɗa ta Breakthrough Therapy daga Cibiyar Kimanta Magunguna ta Hukumar Kayayyakin Lafiya ta Ƙasa ta China. Alamar da aka ƙayyade tana haɗe da Serplulimab don maganin ciwon daji na huhu na ƙananan ƙwayoyin halitta (ES-SCLC) na farko.
YL201 wani sabon tsari ne na ADC wanda ke mai da hankali kan B7H3. Sinadarin B7H3 yana da yawan gaske a kan ƙwayoyin cuta masu cutarwa da ƙwayoyin da ke haifar da cutar kansa na nau'ikan ciwon daji daban-daban, amma yana da ƙarancin bayyanar cututtuka a cikin kyallen jiki na yau da kullun, wanda ke nuna yuwuwar sa a matsayin maganin ADC. An haɓaka YL201 ta amfani da fasahar MediLink's Tumor Microenvironment Activable LINker-payload (TMALIN®) wacce aka haɗa tare da wani takamaiman ƙwayar cuta ta B7H3. A halin yanzu, ana binciken YL201 a cikin nau'ikan ciwon daji masu ƙarfi kuma ya shiga cikin gwaje-gwaje masu mahimmanci a kan Ciwon Huhu na Ƙananan Kwayoyin Halitta da Ciwon Kansa na Nasopharyngeal a China.
### Bayanan Asibiti Masu Inganci: Muhimman Inganci da Tsaro Mai Kyau
A watan Maris na 2025, mujallar kasa da kasa mai suna *Nature Medicine* ta buga bayanai daga gwajin asibiti na Phase 1/1b na YL201 a cikin marasa lafiya da ke fama da ciwon daji mai tsanani. Wannan binciken, wanda ya kunshi marasa lafiya 312, ya nuna:
- **Ingancin Gabaɗaya:** Daga cikin marasa lafiya 287 da ake kimantawa, ƙimar amsawar da aka yi niyya (ORR) ta kasance mai ban sha'awa da kashi 40.8%, ciki har da marasa lafiya 2 da suka sami cikakken amsawa (CR) da kuma marasa lafiya 115 da suka sami wani ɓangare na amsawa (PR). Matsakaicin ƙimar kula da cututtuka (DCR) ya kai kashi 83.6%.
- **Ciwon Kansar Huhu Mai Tsanani Mai Tsanani (ES-SCLC):** A cikin marasa lafiya da aka yi wa magani da maganin chemotherapy na tushen platinum, ORR ya kasance 63.9%, DCR ya kasance 91.7%, kuma matsakaicin rayuwa ba tare da ci gaba ba (mPFS) shine watanni 6.3.
- **Kansa na Nasopharyngeal (NPC):** Daga cikin marasa lafiya 70, ORR shine 48.6%, DCR shine 92.9%, tare da marasa lafiya 2 sun sami cikakken amsawa. Matsakaicin tsawon lokacin amsawa (mDOR) ya kasance har zuwa watanni 8.4.
Waɗannan bayanai sun tabbatar da cikakken ƙarfin aikin hana ƙari da kuma yanayin aminci na YL201 a cikin nau'ikan ciwace-ciwacen da suka ci gaba da yawa, suna shimfida tushe mai ƙarfi don binciken asibiti na gaba da amfani mai faɗi.
### Sashen Ƙasa da Ƙasa na Asibitin Kanjamau na Yankin Kudu na Beijing: Gadarku zuwa Magungunan Ƙasa da Ƙasa
Sashen Kula da Cututtukan Cututtuka na Ƙasa da Ƙasa na Asibitin Birnin Beijing na Kudu yana ci gaba da himma wajen gabatar da fasahohin gano cutar kansa da kuma magance ta a duniya. Muna bin diddigin ci gaban bincike na zamani kuma muna ci gaba da haɗin gwiwa mai ƙarfi da manyan cibiyoyin kimiyya a cikin gida da kuma ƙasashen duniya, muna ƙoƙarin samar wa marasa lafiya na ƙasashen duniya damar samun hanyoyin magance cutar cikin lokaci, ciki har da YL201.
Ƙungiyar Kula da Marasa Lafiya ta Duniya za ta iya samar muku da:
- **Kwamitin Kula da Lafiya na Keɓancewa:** Wata ƙungiya mai fannoni daban-daban (MDT) za ta yi cikakken nazari kan bayanan lafiyarka don tantance ko maganin ADC ya dace da yanayinka.
- **Sauƙaƙe Samun Kulawa:** Taimako wajen samun biza zuwa China, tsara jadawalin shawarwari na ƙwararru, shirya ayyukan fassara, da kuma daidaita shiga asibiti don samun ƙwarewa ba tare da damuwa ba.
### Tuntube Mu Yanzu Don Ƙarin Bayani
Idan kai ko wani ƙaunatacce yana fuskantar ƙalubale da suka shafi ciwon huhu na ƙananan ƙwayoyin halitta, ciwon daji na nasopharyngeal, ko wasu ciwace-ciwacen da suka ci gaba, kuma kuna son ƙarin bayani game da maganin ADC na zamani ko kuma kimanta damar magani, da fatan za a tuntuɓi Sashen Ƙasa da Ƙasa na Asibitin Oncology na Yankin Kudu na Beijing nan da nan. Ƙwararrun Ma'aikatan Kula da Marasa Lafiya na Duniya za su amsa tambayarku cikin awanni 24.
**Bayanin hulda:**
- **Lambar Waya:** 400-880-3716����
- **WeChat:** 17801183037
- **Imel:**
100085_010@163.com
myimmnet@163.com
Mun fahimci cewa hanyar maganin cutar kansa tana da wahala, amma kowace nasara tana nuna sabon bege. Sashen Duniya na Asibitin Oncology na Beijing yana fatan tsayawa tare da ku, ta amfani da fasahar likitanci ta ƙwararru da kulawa mai ɗumi da tausayi, don shawo kan cutar kansa tare da rungumar wayewar rayuwa.
Lokacin Saƙo: Maris-24-2026